Effects of bosentan in patients with severe pulmonary hypertension and mild-to-moderate COPD

G. Prevot, L. Tetu, N. Blot-Souletie, A. Didier (Toulouse, France)

Source: Annual Congress 2009 - Pulmonary circulation I
Session: Pulmonary circulation I
Session type: Thematic Poster Session
Number: 3914
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Prevot, L. Tetu, N. Blot-Souletie, A. Didier (Toulouse, France). Effects of bosentan in patients with severe pulmonary hypertension and mild-to-moderate COPD. Eur Respir J 2009; 34: Suppl. 53, 3914

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of simvastatin on pulmonary hypertension in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 287s
Year: 2007

Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019


Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2003; 22: Suppl. 45, 427s
Year: 2003

Influence of bronchodilators on pulmonary hypertension (PH) in patients with moderate and severe chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 310s
Year: 2005

Bosentan and pulmonary hypertension in patients affected by chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009

Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) and COPD concomitant with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 521s
Year: 2004

Experience with pulmonary selective vasodilator treatment in COPD with severe pulmonary hypertension
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011

Microvascular changes in COPD patients with severe pulmonary hypertension
Source: International Congress 2017 – Imaging and lung disease PH
Year: 2017


Effects of nebulised iloprost on pulmonary function and oxygenation in patients with severe pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 370s
Year: 2002

Acute pulmonary vasoreactivity to beraprost in patients with severe pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 597s
Year: 2002

Effects of sildenafil on secondary pulmonary hypertension in highlanders with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 73s
Year: 2007

Systemic inflammation and pulmonary hypertension in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 142s
Year: 2007

Acute and chronic effects of PDE5-Is on SpO2 in patients with COPD associated pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013


Effects of amlodipine on pulmonary haemodynamics in pulmonary hypertension (PH) secondary to chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 27s
Year: 2002

Effects of different classes of bronchodilators on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease>
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019


Effects of lisinipril on hypertensive COPD and asthma patients
Source: Eur Respir J 2005; 26: Suppl. 49, 718s
Year: 2005

Secondary pulmonary hypertension in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 348s
Year: 2007

Conclusion: treatment of pulmonary hypertension in COPD patients
Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange
Year: 2005

Enalapril in the management of patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2003; 22: Suppl. 45, 241s
Year: 2003

Effects of pulmonary rehabilitation on systemic and pulmonary inflammation in COPD patients
Source: Annual Congress 2010 - Exercise in COPD
Year: 2010